Amble review

Amble: one price advertised, two molecules sold

Amble does the hardest part well. In forty-five states there is no appointment — you fill in an online health review, a clinician reads it, and that is the whole encounter. It names the five states where that is not true, which almost nobody does. The price ladder sits on a public page with no quiz in front of it. For a working mom, that is most of what matters, and it is why this review is not a dismissal. The problem is what the price on that page is a price for.

The advertised number covers one drug

Amble's GLP-1 page sells "Compounded GLP-1 injections" — a heading with no molecule in it — at $179 a month, $160 on three months, $135 on six. Read that as the price of the program and you would budget around $179. It is the semaglutide price. Amble's own intake catalog prices tirzepatide at $329 a month, with $255 and $235 on the prepaid tiers, and none of those three numbers appears on any page you can read first. That is 84% above the advertised figure — $150 a month, $1,800 a year. Worse, the treatment picker where that number lives sits behind an eligibility form that wants your first name, last name, email and phone. The cheap price is free to look at. The expensive one costs you your contact details.

It matters which direction that error runs. A "from" price that turns out to be a floor is ordinary marketing. This is a headline attached to one product while a second product, sold under the same neutral heading, costs half again as much. If you came here for tirzepatide, every number you have seen is wrong. Our cost cheat sheet is built around exactly this gap between the sticker and the bill.

One point of honesty about how we know this. We did not walk the funnel and watch $329 appear on a screen — we read Amble's own product catalog out of the code its intake app ships. What turns that from an inference into a fact is a second, independent source: a complaint on Amble's Better Business Bureau profile, dated 23 June 2026, from a customer "charged $765 via Klarna for a 3-month supply of tirzepatide" — to the dollar, the three-month tirzepatide total in that catalog. So the product is real, the price is real, and it is not on the page.

"Same price, every dose" — with an expiry clause

Flat-by-dose pricing is the thing we reward most after speed, because titration is where dose-scaling plans quietly get expensive — the case is laid out in flat price vs dose-scaling. Amble says "Same price, every dose", and then, in its safety block, that the promise "expires within 24 hours of any price updates" and that pricing "may change at any time … at the discretion of joinamble.com." A flat rate you can be moved off with a day's notice is a promotion, not a pricing model, and it should be read as one. The homepage also advertises "Plans starting at $99 per month"; there is no $99 plan on the GLP-1 page or in the intake catalog.

The $100 you agree to without being told

This is the finding that moved the score. The consent you tick before submitting your intake says "a $100 non-refundable visit and clinical fee will be withheld from my refund." Two screens earlier the same funnel tells you there is no cancellation fee. Search the Terms of Service for "$100", "visit fee" or "clinical fee" and you get nothing — the charge exists in one sentence, at the moment of consent, on a site whose FAQ advertises "no hidden fees." A fee disclosed only where you can no longer comparison-shop is not disclosed in any sense a reader would recognise.

There is no pause button, and stopping is expensive

Amble's exit terms are the firmest on this board. Multi-month plans are paid in full at purchase — "Total price represents a one time purchase paid upfront" — and "All Products are non-refundable." Cancelling future renewals takes fifteen days' notice before your next billing date. The words "pause", "skip" and "defer" appear nowhere in the contract: this is not a poor pause policy, it is the absence of one. A reviewer on Amble's BBB profile describes support declining to cancel and repeatedly offering to "pause" instead — which, if that is how it goes, means a pause exists as a retention offer rather than as a term you can hold anyone to. And the Terms close the last door explicitly, warning that anyone who disputes a charge to get out of a commitment will be "sent to collections and/or have further legal action pursued." Prepay six months, have a hard quarter in month two, and there is no mechanism in the contract that helps you. What a clean off-ramp looks like is the standard this is furthest from.

Two delivery dates, and only one of them is in the contract

Amble's FAQ says medication arrives "on average within 2 days." The consent form you legally attest to says "typical pharmacy fulfillment ranges from 7-10 business days." Both are Amble's own words. Plan around the slower one, because it is the one in the document you signed, and do not let your supply run to zero on the strength of the faster one — see which providers actually ship fastest for how the field compares when the timeline is published honestly.

What it never tells you at all

No compounding pharmacy is named. No clinician, medical director or prescribing group is named. Which states the "all 50 states, restrictions apply" claim excludes is never stated, and the Terms separately warn the service "may not be available in your state." The "4.6 · 2000+ reviews" badge names no review platform. Patient counts contradict each other across two pages — 100,000+ in one place, 250,000+ in another. Naming your pharmacy is the floor for a compounded program, not a bonus; how to vet one explains why. One structural note worth carrying: Amble is a branded skin on a shared telehealth platform — its Terms name Bask Health, Inc. as the pharmacy network provider, the same platform behind Effecty — so it is a storefront rather than an operator. Two Better Business Bureau records cover the brand — one filed under Amble Health in Houston, one under Vaxxen Labs Inc. in Cortland, Ohio, where "Amble Health" is a listed alternate name and where Amble's own Terms send legal notice. Both are rated F and neither is accredited. The Houston record carries a Pattern of Complaints alert and 351 complaints in three years, 179 of them unanswered. Those are complaints the BBB publishes and consumer allegations, not findings of ours — but the volume, and the fact that Amble does not answer most of them, is the kind of thing worth knowing before you prepay six months. One of those complainants names the compounding pharmacy, Perfection Rx. Amble never does.

The bottom line

Amble is worth considering for one specific reader: you want semaglutide, you want to start without producing a weekday video slot, and you are willing to pay $179 month to month rather than prepay anything. That version of Amble is fast, legible and reasonably priced. Every other version has a problem — the tirzepatide price you cannot see until you have started, the $100 you agree to at the last screen, and a contract with no pause and a collections warning in it. If the async start is what drew you here, see who else offers it with the terms written down, or put it next to CoreAge Rx — side by side — before you commit a card.